Key Takeaways

  • Day One Ventures sued nuclear startup Valar Atomics over Series B allocations, exposing how growth funds strip seed investors of pro rata rights.
  • Multi-stage growth funds instruct their legal teams to insert blanket pro rata waiver clauses directly into term sheets to take 100% of new financing rounds.
  • Rory O'Driscoll calculates that suing to invest $10 million to $15 million at a $5 billion to $6 billion valuation when an early check is already worth $100 million to $300 million destroys founder alignment for marginal upside.
  • Standard corporate charters allow a simple majority of preferred shareholders to waive participation rights for every investor in a syndicate.
  • Jason Lemkin's operating rule for seed investors facing broken pro rata promises is simple: raise the objection exactly once with the founder, then drop it completely.

Growth Leads Automatically Strip Seed Allocations

Seed investors treat pro rata rights as an insurance policy: write a check early, take initial product risk, and secure the right to buy proportional shares in future rounds to prevent dilution.

The mechanics of venture financing break this promise. Rory O'Driscoll explains how the legal machinery operates in later stages: “Just to remind everyone, pro rata simply means if you want 5% of the company, you can get 5% of any round... so you can quote protect your ownership. Typically all major investors get that right. But it's typical also that a majority of the investors can waive it for everyone.”

Growth funds demand full round ownership to hit return thresholds. Jason Lemkin explains how routine this exclusion is: “As a seed investor this happens all the time. The big funds in fact they put in their term sheet without even checking it. Their lawyers immediately put in that my pro ratas waived in every single round.” When a multi-stage firm offers capital, founders accept the waiver to close fast, leaving seed backers locked out.

Fighting Over Series B Allocations Destroys Real Gains

When Valar Atomics blocked Day One Ventures from its Series B round, the fund filed a lawsuit. O'Driscoll argues that taking your portfolio company to court at that stage represents a failure of judgment.

“So, you're suing for the right to get 10 or 15 million bucks in at 5 billion, six billion pre when you already own 5% of the company, which is worth $300 million,” O'Driscoll explains. “What are you doing here? Even if it's $100 million, you have your win. Picking this fight's a mistake.”

The math exposes the error. If your seed position sits on an unrealized return worth $100 million to $300 million, fighting over an incremental $10 million check will not move the needle for your fund. What it does is brand you as an adversary across the venture community, while failing to force a reluctant founder to collaborate.

Object Once, Then Let the Round Close

When a founder cuts your allocation, instinct urges you to call counsel. Lemkin argues that legal threats produce negative returns.

“I've observed VCs suing their portfolio companies for doing the wrong thing,” Lemkin notes. “When founders have decided to do this, you just got to get with the program.”

Lemkin applies a strict operating rule derived from his own portfolio experiences, including an incident with Harry Stebbings: “Listen, if you are quote air quote wronged by a founder as a VC, raise it once and let it go. Raise it once.”

State your position once, remind the founder of your early conviction, and see if they offer alternative access. If they refuse, walk away. Once the syndicate votes to strip your rights, the fight is over. Your sole focus is supporting the equity you already hold.

What to Do With This

Audit your seed side letters this week to verify whether your pro rata contains a majority waiver clause. If you are a founder negotiating a Series A or B, tell your incoming lead investor upfront which early supporters you plan to protect before their counsel inserts blanket waiver language into the financing documents.